- Report
- January 2022
- 188 Pages
Global
From €3063EUR$3,185USD£2,627GBP
€4375EUR$4,550USD£3,753GBP
- Report
- April 2023
- 110 Pages
United Kingdom
From €4567EUR$4,750USD£3,918GBP
- Report
- October 2021
- 117 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- October 2021
- 75 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- March 2022
- 172 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- May 2022
- 210 Pages
Global
From €5547EUR$5,769USD£4,759GBP
- Report
- February 2022
- 172 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- September 2019
Global
From €5163EUR$5,370USD£4,430GBP
The Implantable Defibrillator market is a segment of the Medical Devices industry that focuses on the development and sale of devices used to treat cardiac arrhythmias. These devices are implanted in the chest and deliver electrical shocks to the heart in order to restore normal rhythm. Implantable Defibrillators are used to treat a variety of conditions, including ventricular tachycardia and ventricular fibrillation. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments.
The Implantable Defibrillator market is highly competitive, with a number of large players and several smaller companies. Some of the major players in the market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more